COMP <GO>

CELC vs CLOV // EV/EBITDA & P/E VALUATION

Celcuity Inc. (NASDAQ) VS. Clover Health Investments Corp. (Class A) (NASDAQ) • 15-METRIC TALLY: CELC 2 — CLOV 3

■ METRIC PARITY

LAST: $69.30 (-0.23%) • MKT CAP: $3.39B

valuation

—

LAST: $4.58 (-4.38%) • MKT CAP: $2.43B

valuation

—

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CELC VS. CLOV) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	CELC	CLOV	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	—	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	-35.00%	-29.30%	-5.70	CLOV	/roic <GO>
EV/EBITDA & P/E Valuation ACTIVE	—	—	—	TIE	/valuation <GO>
Free Cash Flow Yield	-4.53%	-2.84%	-1.69	CLOV	/fcf-yield <GO>
Operating Margin	—	-4.40%	—	TIE	/operating-margins <GO>
Net Profit Margin	—	-4.40%	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	—	40.30%	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	3.62	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	2/9	3/9	-1.00	CLOV	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	49.3	45.3	+4.01	CELC	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple	—	—	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$3.39B	$2.43B	$958.3M	CELC	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	CELC REV	CLOV REV	CELC GROSS %	CLOV GROSS %	CELC FCF	CLOV FCF
FY 2025	$0	$1.92B	—	—	-$153.5M	-$69.0M
FY 2024	$0	$1.37B	—	—	-$83.7M	$33.3M
FY 2023	$0	$1.26B	—	—	-$53.8M	-$144.7M

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

CELC // BETA —

CLOV // BETA —